Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic

The current COVID-19 pandemic is unprecedented in living memory and is affecting everyone, including our patients. It is increasingly important to provide the optimal management for patients with different non-melanoma skin cancers (NMSC). NMSC surgery has almost completely ceased over recent weeks. This is affecting already overstretched radiotherapy departments, with increasing numbers of patients being referred for definitive radiotherapy. Capacity and demand analysis and forecasting are taking place almost daily in radiotherapy departments across the UK in an attempt to manage this.
Source: Clinical Oncology - Category: Radiology Authors: Tags: Editorial Source Type: research